IS5902A - Notkun á asýlkarnitínum sem miðlum gegn æxli - Google Patents
Notkun á asýlkarnitínum sem miðlum gegn æxliInfo
- Publication number
- IS5902A IS5902A IS5902A IS5902A IS5902A IS 5902 A IS5902 A IS 5902A IS 5902 A IS5902 A IS 5902A IS 5902 A IS5902 A IS 5902A IS 5902 A IS5902 A IS 5902A
- Authority
- IS
- Iceland
- Prior art keywords
- tumor suppressor
- acyl carnitine
- carnitine
- acyl
- somatosstatin
- Prior art date
Links
- MEFKEPWMEQBLKI-AIRLBKTGSA-O S-adenosyl-L-methionine Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H]([NH3+])C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-O 0.000 title 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 title 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 title 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 abstract 1
- 229960001009 acetylcarnitine Drugs 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI002090A IT1302289B1 (it) | 1998-09-30 | 1998-09-30 | Composizioni farmaceutiche ad attivita' antineoplastica |
| PCT/EP1999/007170 WO2000018385A2 (en) | 1998-09-30 | 1999-09-27 | Use of acylcarnitines as antitumour agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5902A true IS5902A (is) | 2001-03-20 |
Family
ID=11380776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5902A IS5902A (is) | 1998-09-30 | 2001-03-20 | Notkun á asýlkarnitínum sem miðlum gegn æxli |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6673839B1 (is) |
| EP (1) | EP1117393B1 (is) |
| JP (1) | JP2002525316A (is) |
| AT (1) | ATE358476T1 (is) |
| AU (1) | AU761357B2 (is) |
| CA (1) | CA2345724C (is) |
| DE (1) | DE69935724T2 (is) |
| DK (1) | DK1117393T3 (is) |
| ES (1) | ES2284267T3 (is) |
| IL (1) | IL142295A (is) |
| IS (1) | IS5902A (is) |
| IT (1) | IT1302289B1 (is) |
| NO (1) | NO20011578L (is) |
| NZ (1) | NZ510803A (is) |
| WO (1) | WO2000018385A2 (is) |
| ZA (1) | ZA200102545B (is) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006347935A (ja) * | 2005-06-15 | 2006-12-28 | Masanori Ogata | 炎症性サイトカインの産生が関与する疾患の予防及び／又は治療のための医薬 |
| CA2681185C (en) * | 2007-03-21 | 2018-05-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| MX2011005593A (es) * | 2008-12-01 | 2011-06-20 | Sigma Tau Ind Farmaceuti | Uso de alcanoil l-carnitina en combinacion con agentes quimioterapeuticos para el tratamiento de neoplasmas. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05339148A (ja) * | 1992-05-28 | 1993-12-21 | T Knight Albert | 血液脳関門を通過する物質 |
| US5504069A (en) * | 1993-02-11 | 1996-04-02 | Biomeasure, Inc. | Inhibition of trauma-induced tumor growth |
| IT1277898B1 (it) * | 1995-08-03 | 1997-11-12 | Mendes Srl | Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie |
| WO1997006788A1 (en) * | 1995-08-14 | 1997-02-27 | Janssen Pharmaceutica N.V. | Transdermal administration of vorozole |
| JPH11292787A (ja) | 1995-08-15 | 1999-10-26 | Asahi Chem Ind Co Ltd | 生理活性ペプチドを含有する経粘膜投与製剤 |
| IT1283951B1 (it) | 1996-03-15 | 1998-05-07 | Mendes Srl | Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di |
| PT1100589E (pt) * | 1998-07-30 | 2005-05-31 | Sigma Tau Ind Farmaceuti | Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena |
-
1998
- 1998-09-30 IT IT1998MI002090A patent/IT1302289B1/it active IP Right Grant
-
1999
- 1999-09-27 EP EP99947427A patent/EP1117393B1/en not_active Expired - Lifetime
- 1999-09-27 IL IL14229599A patent/IL142295A/en not_active IP Right Cessation
- 1999-09-27 JP JP2000571904A patent/JP2002525316A/ja active Pending
- 1999-09-27 AU AU60877/99A patent/AU761357B2/en not_active Ceased
- 1999-09-27 CA CA002345724A patent/CA2345724C/en not_active Expired - Fee Related
- 1999-09-27 WO PCT/EP1999/007170 patent/WO2000018385A2/en not_active Ceased
- 1999-09-27 ES ES99947427T patent/ES2284267T3/es not_active Expired - Lifetime
- 1999-09-27 DK DK99947427T patent/DK1117393T3/da active
- 1999-09-27 AT AT99947427T patent/ATE358476T1/de not_active IP Right Cessation
- 1999-09-27 NZ NZ510803A patent/NZ510803A/en not_active IP Right Cessation
- 1999-09-27 DE DE69935724T patent/DE69935724T2/de not_active Expired - Lifetime
- 1999-09-27 US US09/806,153 patent/US6673839B1/en not_active Expired - Fee Related
-
2001
- 2001-03-20 IS IS5902A patent/IS5902A/is unknown
- 2001-03-28 ZA ZA200102545A patent/ZA200102545B/en unknown
- 2001-03-28 NO NO20011578A patent/NO20011578L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20011578L (no) | 2001-05-30 |
| ATE358476T1 (de) | 2007-04-15 |
| DK1117393T3 (da) | 2007-08-06 |
| ZA200102545B (en) | 2001-09-28 |
| EP1117393B1 (en) | 2007-04-04 |
| ES2284267T3 (es) | 2007-11-01 |
| WO2000018385A2 (en) | 2000-04-06 |
| JP2002525316A (ja) | 2002-08-13 |
| ITMI982090A1 (it) | 2000-03-30 |
| NZ510803A (en) | 2003-08-29 |
| CA2345724C (en) | 2009-05-19 |
| US6673839B1 (en) | 2004-01-06 |
| WO2000018385A3 (en) | 2000-05-25 |
| CA2345724A1 (en) | 2000-04-06 |
| IL142295A (en) | 2004-08-31 |
| DE69935724T2 (de) | 2007-12-27 |
| AU6087799A (en) | 2000-04-17 |
| DE69935724D1 (en) | 2007-05-16 |
| AU761357B2 (en) | 2003-06-05 |
| NO20011578D0 (no) | 2001-03-28 |
| IL142295A0 (en) | 2002-03-10 |
| EP1117393A2 (en) | 2001-07-25 |
| IT1302289B1 (it) | 2000-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HN1999000125A (es) | Nuevos derivados sustituidos del pirazol | |
| HRP20030383B1 (hr) | Laktamski spoj | |
| TR199902400T2 (xx) | Fungusit etkinlik g�steren terkiplerin birle�imleri. | |
| PT1109812E (pt) | Pirrolobenzodiazepinas | |
| AP2002002637A0 (en) | Novel piperazine | |
| DK1297013T3 (da) | Anvendelse af TACI som antitumormiddel | |
| HRP20010117B1 (en) | Novel salt form of pantoprazole | |
| BR0116217A (pt) | Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas | |
| ES2191208T3 (es) | Oxiimino-pregnano-carbolactonas. | |
| ES2187261B2 (es) | Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos. | |
| BR0114903A (pt) | 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| SE9901077D0 (sv) | Novel use | |
| EA200300450A1 (ru) | Фармацевтические растворы соединений модафинила | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| BR0007922A (pt) | Compostos calcilìticos | |
| EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
| TR200002203T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
| EA200200948A1 (ru) | Лечение псориаза | |
| ES2052105T3 (es) | Gilanteno: principio anti-metastasico de sanguijuela de america del sur haementaria ghilianii. | |
| NO20011578L (no) | Anvendelse av acylkarnitiner som antitumormidler | |
| ES2157419T3 (es) | Arilazadioxacicloalquenos substituidos, fungicidas. | |
| ATE249204T1 (de) | Spray, enthaltend ubichinon qn | |
| PL369295A1 (en) | Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor | |
| EA200400382A1 (ru) | Применение специфической дозы фондапаринукса натрия для лечения окс |